[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335626-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335626-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","survival-outcomes-for-men-over-80-years-undergoing-transrectal-ultrasound-guided-prostate-biopsy-a-prospective-analysis","Survival Outcomes for Men over 80 Years Undergoing Transrectal Ultrasound-Guided Prostate Biopsy - A Prospective Analysis","","Prostate cancer is common among elderly men, and transrectal ultrasound (TRUS) biopsy remains a standard diagnostic approach despite meaningful risks such as sepsis, acute urinary retention, and rectal bleeding. This prospective study evaluated cancer-specific survival in 200 men aged over 80 years who underwent TRUS biopsy between 2005 and 2015, using electronic follow-up to analyze outcomes. Elevated PSA, advanced ISUP grade, metastases, and biopsy-related complications were linked to shorter survival, while comorbidities showed no effect on survival probability.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/survival-outcomes-for-men-over-80-years-undergoing-transrectal-ultrasound-guided-prostate-biopsy-a-prospective-analysis/335626/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/survival-outcomes-for-men-over-80-years-undergoing-transrectal-ultrasound-guided-prostate-biopsy-a-prospective-analysis/335626.png","ImageObject",300,407,{"name":42,"@type":43},"Clementine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of this study on men over 80?","Question",{"text":63,"@type":64},"To evaluate cancer-specific survival outcomes after transrectal ultrasound (TRUS) biopsy and determine whether TRUS biopsy provided a survival advantage for men aged over 80.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were participants selected and followed?",{"text":68,"@type":64},"Between January 2005 and December 2015, 200 patients with elevated PSA levels (>4.0 ng/mL) and/or abnormal digital rectal examination underwent TRUS biopsy and were followed until death using an electronic system and unique identifiers.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were associated with poorer survival?",{"text":72,"@type":64},"Higher PSA levels, development of metastases, advanced ISUP grade group 8–10, and biopsy-related complications were associated with shorter survival times, along with higher mortality risk in the oldest age groups.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335626,1790627708,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":4},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Article  \nSurvival Outcomes for Men over 80 Years Undergoing Transrectal Ultrasound-Guided Prostate Biopsy: A Prospective Analysis  \nDareen Alghamdi 1,2, *, Neil Kernohan 3, Chunhui Li 4, * and Ghulam Nabi 5  \nCitation: Alghamdi, D.; Kernohan, N.; Li, C.; Nabi, G. Survival Outcomes for Men over 80 Years Undergoing Transrectal Ultrasound-Guided Prostate Biopsy: A Prospective Analysis. Cancers 2024, 16, 3995 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cancers16233995  \nAcademic Editor: Aria Baniahmad  \nReceived: 29 October 2024  \nRevised: 24 November 2024  \nAccepted: 25 November 2024  \nPublished: 28 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Division of Imaging Sciences and Technology, School of Medicine, Ninewells Hospital, University of Dundee, Dundee DD1 9SY, UK  \n2 Radiology Department, College of Applied Medical Sciences, Imam Abdulrahman bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia  \n3 Department of Pathology, Ninewells Hospital, Dundee DD9 1SY, UK; [neil.kernohan@nhs.scot](neil.kernohan@nhs.scot)  \n4 School of Science and Engineering, University of Dundee, Dundee DD1 4HN, UK  \n5 Division of Cancer Research, School of Medicine, Ninewells Hospital, University of Dundee, Dundee DD1 9SY, UK; [g.nabi@dundee.ac.uk](g.nabi@dundee.ac.uk)  \n* Correspondence: [dalghamdi@dundee.ac.uk or daalghamdi@iau.edu.sa](dalghamdi@dundee.ac.uk or daalghamdi@iau.edu.sa) (D.A.); [c.li@dundee.ac.uk](c.li@dundee.ac.uk) (C.L.)  \nSimple Summary: Prostate cancer is common among older men, and its diagnosis often involves a procedure called transrectal ultrasound (TRUS) biopsy, which helps detect cancer but also carries risks like infection and bleeding, particularly for elderly patients. This study evaluated the survival of men over 80 years of age to determine if undergoing a TRUS biopsy might improve their chances of surviving prostate cancer. By examining the records of 200 patients who had this biopsy, the study identified factors linked to poorer survival, including high levels of prostate-specific antigen, advanced cancer grade, and metastases. These findings can assist in a more accurate evaluation of the risks associated with TRUS biopsy in elderly patients and may guide future research toward developing safer or alternative strategies for diagnosing and managing prostate cancer in this population.  \nAbstract: Introduction: Prostate cancer is the second most prevalent cancer among elderly males in Western countries. TRUS biopsy remains a standard diagnosing approach for prostate cancer but poses notable risks, particularly in older men, including complications such as sepsis, acute retention, and rectal bleeding, which can lead to substantial morbidity and mortality. This study aimed to evaluate cancer-specific survival outcomes in men aged over 80 years and whether there is any cancer-specific survival advantage for TRUS biopsy procedure. Methods: Between January 2005 and December 2015, we studied outcomes of 200 patients (median age, 82 years) with elevated prostate-specific antigen (PSA) levels (>4.0 ng/mL) and/or abnormal digital rectal examination (DRE) who underwent TRUS biopsy. Each participant was followed up until death using an electronic system and a unique identifier in a defined geographical area. Cancer-specific and overall survival analyses were carried out utilising SPSS, while R Project was employed to construct and evaluate two nomograms survival duration and predict the risk of death post-biopsy. All statistical tests were two-tailed, with significance set at p \u003C 0.05. Results: Amongst the participants, only 24 patients were alive at the ","cbCairYH1X7oChhZ","https://ap.wps.com/l/cbCairYH1X7oChhZ","pdf",3309670,"English","# Introduction\n## Study background and rationale\n# Methods\n## Participants and follow-up\n## Statistical analyses and nomograms\n# Results\n## Survival findings\n## Prognostic factors\n# Discussion\n## Interpretation of survival predictors","[{\"question\":\"What was the purpose of this study on men over 80?\",\"answer\":\"To evaluate cancer-specific survival outcomes after transrectal ultrasound (TRUS) biopsy and determine whether TRUS biopsy provided a survival advantage for men aged over 80.\"},{\"question\":\"How were participants selected and followed?\",\"answer\":\"Between January 2005 and December 2015, 200 patients with elevated PSA levels (\\u003e4.0 ng/mL) and/or abnormal digital rectal examination underwent TRUS biopsy and were followed until death using an electronic system and unique identifiers.\"},{\"question\":\"Which factors were associated with poorer survival?\",\"answer\":\"Higher PSA levels, development of metastases, advanced ISUP grade group 8–10, and biopsy-related complications were associated with shorter survival times, along with higher mortality risk in the oldest age groups.\"}]","Survival Outcomes for Men over 80 Years Undergoing Transrectal Ultrasound-Guided Prostate Biopsy - A Prospective Analysis | PDF",1790011700,48]